Yonghe Medical Group Co., Ltd.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. carries a market capitalization of 85.56M, placing it among publicly traded companies globally. Its enterprise value stands at 53.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Yonghe Medical Group Co., Ltd.'s next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. has 500.11M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Yonghe Medical Group Co., Ltd.'s stock has gained approximately 10.09% over the past 52 weeks. The 50-day moving average sits at 0.24, while the 200-day moving average is 0.22.

As of December 31, 2025, Yonghe Medical Group Co., Ltd. holds 91.19M in cash and equivalents against 58.99M in total debt, resulting in a net debt position of -85.08M. Total book value stands at 95.92M, with working capital of 37.03M providing operational flexibility.